← Open Payments lookup

LISA RAHAIM: Open Payments

NPI 1982703914 · WOODBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,082 in 64 payments from 14 companies in 2025. Trend: 2023 $1,607 · 2024 $1,174 · 2025 $1,082

Food & beverage: $1,082
CompanyPaymentsAmount
ABBVIE INC.14$196
Regeneron Healthcare Solutions, Inc.8$152
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$152
Janssen Biotech, Inc.5$94
Phathom Pharmaceuticals, Inc.6$85
Lilly USA, LLC4$83
Gilead Sciences, Inc.5$81
Takeda Pharmaceuticals U.S.A., Inc.3$58
Madrigal Pharmaceuticals3$53
Ardelyx, Inc.2$42

Products named: DUPIXENT, RINVOQ, XIFAXAN, TREMFYA, VOQUEZNA, OMVOH, ENTYVIO, REZDIFFRA.

Industry payments across NJ — which companies pay providers there.